UY39466A - Compuestos y composiciones para el tratamiento de la criptosporidiosis - Google Patents
Compuestos y composiciones para el tratamiento de la criptosporidiosisInfo
- Publication number
- UY39466A UY39466A UY0001039466A UY39466A UY39466A UY 39466 A UY39466 A UY 39466A UY 0001039466 A UY0001039466 A UY 0001039466A UY 39466 A UY39466 A UY 39466A UY 39466 A UY39466 A UY 39466A
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- cryptosporidiosis
- treatment
- compositions
- symptomatology
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063091866P | 2020-10-14 | 2020-10-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39466A true UY39466A (es) | 2022-05-31 |
Family
ID=78302850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039466A UY39466A (es) | 2020-10-14 | 2021-10-12 | Compuestos y composiciones para el tratamiento de la criptosporidiosis |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12018024B2 (enExample) |
| EP (1) | EP4229055B1 (enExample) |
| JP (1) | JP7791184B2 (enExample) |
| CN (1) | CN116368137A (enExample) |
| AR (1) | AR123766A1 (enExample) |
| AU (1) | AU2021362803A1 (enExample) |
| CA (1) | CA3197199A1 (enExample) |
| MX (1) | MX2023004435A (enExample) |
| PY (1) | PY2189412A (enExample) |
| TW (1) | TW202229277A (enExample) |
| UY (1) | UY39466A (enExample) |
| WO (1) | WO2022079616A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR132352A1 (es) * | 2023-04-13 | 2025-06-18 | Syngenta Crop Protection Ag | Derivados de imidazo[1,2-a]pirazina |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2925757T1 (en) * | 2012-11-19 | 2018-01-31 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| TW201728325A (zh) * | 2016-01-21 | 2017-08-16 | 諾華公司 | 治療隱孢子蟲病之化合物及組合物 |
| GB201700692D0 (en) * | 2017-01-16 | 2017-03-01 | Salvensis | Novel compounds and their use in the treatment of schistosomiasis |
-
2021
- 2021-10-12 JP JP2023522570A patent/JP7791184B2/ja active Active
- 2021-10-12 WO PCT/IB2021/059376 patent/WO2022079616A1/en not_active Ceased
- 2021-10-12 MX MX2023004435A patent/MX2023004435A/es unknown
- 2021-10-12 AU AU2021362803A patent/AU2021362803A1/en active Pending
- 2021-10-12 EP EP21794994.0A patent/EP4229055B1/en active Active
- 2021-10-12 AR ARP210102815A patent/AR123766A1/es unknown
- 2021-10-12 TW TW110137677A patent/TW202229277A/zh unknown
- 2021-10-12 CA CA3197199A patent/CA3197199A1/en active Pending
- 2021-10-12 PY PY202102189412A patent/PY2189412A/es unknown
- 2021-10-12 US US17/499,663 patent/US12018024B2/en active Active
- 2021-10-12 UY UY0001039466A patent/UY39466A/es not_active Application Discontinuation
- 2021-10-12 CN CN202180069247.7A patent/CN116368137A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220112189A1 (en) | 2022-04-14 |
| EP4229055A1 (en) | 2023-08-23 |
| CA3197199A1 (en) | 2022-04-21 |
| AR123766A1 (es) | 2023-01-11 |
| EP4229055B1 (en) | 2026-03-04 |
| PY2189412A (es) | 2022-05-17 |
| US12018024B2 (en) | 2024-06-25 |
| CN116368137A (zh) | 2023-06-30 |
| WO2022079616A1 (en) | 2022-04-21 |
| MX2023004435A (es) | 2023-05-08 |
| JP2023545452A (ja) | 2023-10-30 |
| JP7791184B2 (ja) | 2025-12-23 |
| TW202229277A (zh) | 2022-08-01 |
| AU2021362803A1 (en) | 2023-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022010460A2 (es) | Compuestos tricíclicos sustituidos | |
| CR20220312A (es) | Compuestos tricíclicos sustituidos | |
| CO2026005655A2 (es) | Inhibidor de pan-kras y uso del mismo en medicinas | |
| MX2022000271A (es) | Inhibidores de la quinasa progenitora hematopoyetica 1 y usos de los mismos. | |
| DOP2024000039A (es) | Derivados de quinolina como inhibidores de la integrina alfa4beta7 | |
| MX2022004451A (es) | Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1. | |
| MX2021010122A (es) | Compuestos de imidazopiridinilo y su uso para el tratamiento de trastornos neurodegenerativos. | |
| UY39625A (es) | Derivados tricíclicos útiles como inhibidores de parp7 | |
| CO2023001668A2 (es) | Derivados de 1h-benzo[d]imidazol como inhibidores de tlr9 para el tratamiento de fibrosis | |
| UY39181A (es) | COMPUESTOS Y COMPOSICIONES PARA INHIBIR LA ACTIVIDAD DE HIF2a Y SUS MÉTODOS DE USO | |
| CO2019004004A2 (es) | Composición farmacéutica y método para el tratamiento de la enfermedad del hígado graso no alcohólico | |
| MX2025002817A (es) | Compuestos para el tratamiento del cancer | |
| CL2018001881A1 (es) | Compuestos y composiciones para el tratamiento de la criptoporidiosis | |
| AR128109A1 (es) | Spiros y análogos relacionados para inhibir yap / taz-tead | |
| MX2022011240A (es) | Azálidos de urea inmunomoduladores. | |
| PY2189412A (es) | Compuestos y composiciones para el tratamiento de la criptosporidiosis | |
| DOP2019000299A (es) | Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias | |
| CO2022006942A2 (es) | Compuestos de 1,8-naftiridin-2-ona para el tratamiento de una enfermedad autoinmunitaria | |
| CO2024002712A2 (es) | Azálidos inmunomoduladores | |
| CL2024001524A1 (es) | Derivados de naftiridinona para el tratamiento de una enfermedad o un trastorno | |
| MX2019003585A (es) | Derivados de tetrahidropiridina y su uso como agentes antibacterianos. | |
| MX2022015532A (es) | Inhibidores selectivos de hdac6 y usos de los mismos. | |
| CR20220162A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| AR131945A1 (es) | Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno | |
| AR131358A1 (es) | Derivados de imidazotriazina como moduladores de il-17 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20260415 |